Basic Mechanisms and Emerging Therapeutic Strategies for Spinal Cord Injury
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 25 May 2026 | Viewed by 2
Special Issue Editors
Interests: spinal cord injury; nerve injuries; drug delivery; lipid nanoparticles
Special Issue Information
Dear Colleagues,
Spinal cord injury (SCI) results in sensory, motor, and autonomic impairments, along with other associated medical conditions that severely decrease the patient's quality of life. Despite the considerable economic and societal challenges, no clinical therapy is available for substantial recovery of functional deficits after SCI. However, over the past few decades, impactful progress has been made in basic science research and translational studies aimed at treating SCI.
This Special Issue highlights the significant advances made in reducing secondary damage after SCI and progress toward regeneration after SCI. Notable progress has been achieved in understanding the signaling cues and cellular infiltration involved in post-injury inflammation. Additionally, there have been substantial improvements in promoting neural repair through the use of stem cells, neurotrophic factors, degradation of inhibitory extracellular matrix components, and innovations in drug delivery methods.
We therefore invite researchers to submit high-quality original research articles, communications, and review articles across all fields related to SCI, with a focus on basic cellular and molecular mechanisms.
Dr. Daniel J. Hellenbrand
Dr. Angela R. Filous
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- spinal cord injury
- neuroinflammation
- neural regeneration
- axon growth
- neurons
- glial cells
- oligodendrocytes
- myelin
- astrocytes
- microglia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
